Search results
'I'm a Rheumatologist, and This Is the #1 Habit to Break ASAP if You Have Inflammation'
Parade via AOL· 12 hours agoAfter all, it's also the body’s defense mechanism that, at more serious levels, can contribute to...
Arthritis is common, especially among seniors. Here's what causes it.
USA Today· 4 days agoFew medical conditions seem as inevitable when aging as does arthritis. It's an understandable...
More Tender Than Swollen Joints Worsen Outcomes in Early RA
Medscape· 7 days agoPatients with early rheumatoid arthritis who had higher tender-swollen joint differences showed...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
AbbVie's tight grip on Humira market raises concerns about biosimilars By Reuters
Investing.com· 6 days agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...
New drug in Duke-led clinical trial shows improvement in people with common autoimmune disease
WUNC Chapel Hill· 6 days agoA new drug has shown benefits in clinical trials for one of the most common autoimmune diseases. Sjögren’s disease affects an estimated 1 to 4 million people in the United States. “About a quarter ...
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and...
KOLR - KSFX Ozarks· 11 hours agoProtalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by ...